Biocon Archives - Express Pharma

Biocon Biologics signs US settlement with Regeneron to Launch Yesafili Biosimilar by 2026

Biocon’s S&P Global ESG Score improves to 69 for 2024

Innovation, partnerships and best practices: Priorities for biopharma in 2025

Biocon receives EIR with VAI status

17th CPHI & PMEC India Expo to highlight advancements in pharma industry

Biocon and Dr Reddy’s featured in Science Magazine’s Top Employers List

Biocon signs licensing agreement with Tabuk Pharmaceuticals for GLP-1 products

Budget 2024-25 prioritises R&D, education and business for MSMEs

Biocon appoints Mukesh Kamnath as interim CFO

Biocon partners with Handok to commercialise Liraglutide in South Korea